Options: Show MedDRA Preferred Terms
| Side effect | Data for drug | Placebo | Labels | ||
|---|---|---|---|---|---|
| 1 | 2 | 3 | |||
| Flushing | 1% - 29.2% | x | x | ||
| Erythema | 0% - 0.6% | x | x | ||
| Wheezing | 0% - 0.3% | x | x | ||
| Pruritus | 0% - 0.4% | x | x | ||
| Anaphylactic shock | postmarketing | x | |||
| Edema cerebral | postmarketing | x | |||
| Connective tissue disorder | postmarketing | x | |||
| Immune system disorder | postmarketing | x | |||
| Myopathy | postmarketing | x | |||
| Nervous system disorder | postmarketing | x | |||
| Convulsion | postmarketing | x | x | x | |
| Uremia | postmarketing | x | |||
| Urticaria | postmarketing, 0% - 0.2% | x | x | x | |
| Trauma | postmarketing | x | |||
| Muscular weakness | postmarketing | x | |||
| Unspecified disorder of skin and subcutaneous tissue | postmarketing | x | |||
| Encephalitis viral | postmarketing | x | |||
| Anaphylactoid reaction | postmarketing | x | x | ||
| Hypoxic-ischaemic encephalopathy | postmarketing | x | |||
| Bronchospasm | x | x | |||
| Dyspnoea | x | x | |||
| Rash | x | x | |||
| Cardiac arrest | x | x | |||
| Hypersensitivity | x | x | |||
| Hypotension | x | x | x | ||
| Laryngospasm | x | x | |||
| Mediastinal disorder | x | ||||
| Tachycardia | x | x | |||
| Angiopathy | x | ||||
| Mean arterial pressure | x | x | |||
| Bradycardia | x | x | |||
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |